Holen Sie sich die Stockscreener-App
12.10
1.83%
-0.22
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.32
Offen:
$12.44
24-Stunden-Volumen:
2.05M
Relative Volume:
0.40
Marktkapitalisierung:
$2.42B
Einnahmen:
$3.68B
Nettoeinkommen (Verlust:
$-627.00M
KGV:
-3.8441
EPS:
-3.1477
Netto-Cashflow:
$104.00M
1W Leistung:
+14.00%
1M Leistung:
+20.95%
6M Leistung:
-2.22%
1J Leistung:
-24.12%
1-Tages-Spanne:
$12.04
$12.44
1-Wochen-Bereich:
$10.61
$12.48
52-Wochen-Spanne:
$9.405
$16.96
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
12.10 | 2.33B | 3.68B | -627.00M | 104.00M | -3.1477 |
ISRG
Intuitive Surgical Inc
|
426.49 | 150.88B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.46 | 43.56B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.81 | 36.52B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.22 | 33.97B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.34 | 30.41B | 5.54B | 1.52B | 1.74B | 10.37 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Sell |
| 2026-02-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Dentsply Sirona stock rating held at Neutral by Piper Sandler - Investing.com
DENTSPLY SIRONA Inc. (XRAY)’s Shares Are Flat Since Cramer Commented On Them - Yahoo Finance Singapore
From the first dental MRI to orthodontic AI: Four FDA clearances reshaping dentistry - Oral Health Group
Rebecca Whitney assumes CEO role at Young Innovations - DrBicuspid.com
XRAYDENTSPLY Sirona Inc Options - Finviz
DENTSPLY SIRONA (XRAY) On 5 Million CEREC Restorations And The Undervalued Stock Narrative - Sahm
PDS Health and Dentsply Sirona Surpass 5 Million CEREC Chairside Restorations - Quiver Quantitative
Millions of same-day dental restorations: PDS Health hits 5M - Stock Titan
Form 4 Dentsply Sirona Inc For: 1 July By Investing.com - Investing.com UK
[Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity - Stock Titan
Guttacore Obturators Size #25Pack Of 30, Tulsa Dental / Dentsply (Free Shipping) - Santo André BIZ
Does Dentsply Sirona’s (XRAY) Index Shift Recast Its Role in Dental Innovation Leadership? - simplywall.st
Seller dominance drives Dentsply Sirona stock down to $10.54 in weak session - Traders Union
DENTSPLY SIRONA : PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry - marketscreener.com
Dentsply Sirona and HeyGears expand digital denture collaboration to one-piece production with Lucitone - Dental Tribune US
Precision Trading with Dentsply Sirona Inc. (XRAY) Risk Zones - Stock Traders Daily
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) dropped from Russell 1000 Index - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) added to Russell 2000 Index - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) dropped from Russell Midcap Value Benchmark - marketscreener.com
iCAT and BluePort Legal launch UPC battle against dental tech giant Dentsply - JUVE Patent
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) added to Russell 2000 Value Benchmark - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) dropped from Russell 1000 Value Benchmark - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) dropped from Russell 1000 Dynamic Index - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) dropped from Russell Midcap Index - marketscreener.com
Daily Brief Health Care: AxoGen Inc, Dentsply International and more - Smartkarma
DENTSPLY SIRONA, Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh - TradingView
Enterprise value to revenue forward of DENTSPLY SIRONA Inc. – NASDAQ:XRAY - TradingView
Tranche Update on DENTSPLY SIRONA Inc.'s Equity Buyback Plan announced on March 16, 2005. - marketscreener.com
Enterprise value to revenue forward of DENTSPLY SIRONA, Inc. – FWB:DY2 - TradingView
Gothenburg hosts Implant Solutions World Summit 2026 - Dental Tribune US
Enterprise value to EBIT forward of DENTSPLY SIRONA Inc. – NASDAQ:XRAY - TradingView
Price to book forward of DENTSPLY SIRONA, Inc. – FWB:DY2 - TradingView
Enterprise value to EBIT forward of DENTSPLY SIRONA, Inc. – FWB:DY2 - TradingView
DENTSPLY SIRONA, Inc. Actuals & Estimates (NASDAQ:XRAY) - TradingView
XRAY Technical Analysis & Stock Price Forecast - Intellectia AI
Price to earnings forward of DENTSPLY SIRONA Inc. – NASDAQ:XRAY - TradingView
XRAY Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of DENTSPLY SIRONA Inc. – NASDAQ:XRAY - TradingView
Dental Equipment & Technology Stocks Q1 In Review: Dentsply Sirona (NASDAQ:XRAY) Vs Peers - Yahoo Finance
How Investors May Respond To DENTSPLY SIRONA (XRAY) Appointing John C. Fortson As CFO And EVP - Sahm
Dentsply Sirona StockLong-term business model under scrutiny - AD HOC NEWS
DENTSPLY SIRONA (XRAY) Stock Could Be 78% Undervalued After CFO Appointment - Sahm
Thursday insider buys and sells: Directors load up on healthcare By Investing.com - Investing.com Nigeria
Dentsply Sirona director Jonathan Mazelsky buys $101,400 in shares - Investing.com UK
XRAY News | DENTSPLY SIRONA INC (NASDAQ:XRAY) - ChartMill
Dentsply Sirona director Jonathan Mazelsky buys $101,400 in shares By Investing.com - Investing.com Canada
Dentsply Sirona (XRAY) director amends Form 4 to show share purchase - Stock Titan
Dentsply Sirona (XRAY) SVP details stock, RSU, phantom and option holdings - Stock Titan
DENTSPLY SIRONA Inc (XRAY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mitsui Chemicals to acquire Ultradent - DrBicuspid.com
DENTSPLY SIRONA Inc (XRAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dentsply Sirona Inc-Aktie (XRAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MCKEON BRIAN P | Director |
Jun 12 '26 |
Buy |
10.12 |
10,000 |
101,200 |
10,000 |
| Gladden Brian T | Director |
Jun 15 '26 |
Buy |
10.02 |
9,985 |
100,000 |
61,849 |
| HOLDEN BETSY D | Director |
Jun 11 '26 |
Buy |
9.88 |
10,086 |
99,692 |
87,528 |
| Barber Michael J | Director |
Jun 11 '26 |
Buy |
9.88 |
15,175 |
150,005 |
55,943 |
| LUCIER GREGORY T | Director |
Mar 09 '26 |
Buy |
12.45 |
15,000 |
186,675 |
65,000 |
| Forbes James D | Director |
Mar 09 '26 |
Buy |
12.48 |
5,000 |
62,400 |
10,000 |
| LUCIER GREGORY T | Director |
Mar 02 '26 |
Buy |
14.24 |
27,555 |
392,521 |
27,555 |
| LUCIER GREGORY T | Director |
Mar 03 '26 |
Buy |
14.03 |
22,445 |
314,858 |
50,000 |
2.23%
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):